dc.contributor.author |
Omotayo, OP
|
|
dc.contributor.author |
Lemmer, Yolandy
|
|
dc.contributor.author |
Mason, S
|
|
dc.date.accessioned |
2024-07-22T06:32:37Z |
|
dc.date.available |
2024-07-22T06:32:37Z |
|
dc.date.issued |
2024-03 |
|
dc.identifier.citation |
Omotayo, O., Lemmer, Y. & Mason, S. 2024. A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders. <i>Journal of Cannabis Research, 14(6).</i> http://hdl.handle.net/10204/13724 |
en_ZA |
dc.identifier.issn |
2522-5782 |
|
dc.identifier.uri |
https://doi.org/10.1186/s42238-024-00222-2
|
|
dc.identifier.uri |
http://hdl.handle.net/10204/13724
|
|
dc.description.abstract |
The treatment of diverse diseases using plant-derived products is actively encouraged. In the past few years, cannabidiol (CBD) has emerged as a potent cannabis-derived drug capable of managing various debilitating neurological infections, diseases, and their associated complications. CBD has demonstrated anti-inflammatory and curative effects in neuropathological conditions, and it exhibits therapeutic, apoptotic, anxiolytic, and neuroprotective properties. However, more information on the reactions and ability of CBD to alleviate brain-related disorders and the neuroinflammation that accompanies them is needed. |
en_US |
dc.format |
Fulltext |
en_US |
dc.language.iso |
en |
en_US |
dc.relation.uri |
https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-024-00222-2 |
en_US |
dc.source |
Journal of Cannabis Research, 14(6) |
en_US |
dc.subject |
Cannabis research |
en_US |
dc.subject |
Cannabidiol |
en_US |
dc.subject |
CBD |
en_US |
dc.subject |
Brain-related disorders |
en_US |
dc.title |
A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders |
en_US |
dc.type |
Article |
en_US |
dc.description.pages |
26 |
en_US |
dc.description.note |
© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. |
en_US |
dc.description.cluster |
Chemicals |
en_US |
dc.description.impactarea |
BT: Bioprocessing |
en_US |
dc.identifier.apacitation |
Omotayo, O., Lemmer, Y., & Mason, S. (2024). A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders. <i>Journal of Cannabis Research, 14(6)</i>, http://hdl.handle.net/10204/13724 |
en_ZA |
dc.identifier.chicagocitation |
Omotayo, OP, Yolandy Lemmer, and S Mason "A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders." <i>Journal of Cannabis Research, 14(6)</i> (2024) http://hdl.handle.net/10204/13724 |
en_ZA |
dc.identifier.vancouvercitation |
Omotayo O, Lemmer Y, Mason S. A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders. Journal of Cannabis Research, 14(6). 2024; http://hdl.handle.net/10204/13724. |
en_ZA |
dc.identifier.ris |
TY - Article
AU - Omotayo, OP
AU - Lemmer, Yolandy
AU - Mason, S
AB - The treatment of diverse diseases using plant-derived products is actively encouraged. In the past few years, cannabidiol (CBD) has emerged as a potent cannabis-derived drug capable of managing various debilitating neurological infections, diseases, and their associated complications. CBD has demonstrated anti-inflammatory and curative effects in neuropathological conditions, and it exhibits therapeutic, apoptotic, anxiolytic, and neuroprotective properties. However, more information on the reactions and ability of CBD to alleviate brain-related disorders and the neuroinflammation that accompanies them is needed.
DA - 2024-03
DB - ResearchSpace
DP - CSIR
J1 - Journal of Cannabis Research, 14(6)
KW - Cannabis research
KW - Cannabidiol
KW - CBD
KW - Brain-related disorders
LK - https://researchspace.csir.co.za
PY - 2024
SM - 2522-5782
T1 - A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders
TI - A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders
UR - http://hdl.handle.net/10204/13724
ER -
|
en_ZA |
dc.identifier.worklist |
28075 |
en_US |